Mannose Binding Lectin and C3 Serum Levels in Coronary Artery Disease: A Cross-Sectional Study

References

• 7th Brazilian Guideline on Hypertension. (2016). Sociedade Brasileira de Cardiologia, 107(3). Retrieved June 14, 2020, from http://publicacoes.cardiol.br/2014/diretrizes/2016/05_HIPERTENSAO_ARTERIAL.pdf
   Google Scholar
• Ajjan, R., Grant, P. J., Futers, T. S., Brown, J. M., Cymbalista, C. M., Boothby, M., & Carter, A. (2005). Complement C3 and C-reactive protein levels in patients with stable coronary artery disease. Thrombosis & Haemostasis, 94(11), 1048–1053. https://doi.org/10.1160/TH05-06-0384
   PubMedGoogle Scholar
• Albert, M. A., Rifai, N., & Ridker, P. M. (2001). Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vascular Medicine, 6(3), 145–149. https://doi.org/10.1177/1358836x0100600304
   PubMed Web of Science ®Google Scholar
• Beltrame, M. H., Catarino, S. J., Goeldner, I., Boldt, A. B. W., Reason, I. J., & de, M. (2015). The lectin pathway of complement and rheumatic heart disease. Frontiers in Pediatrics, 2, 148. https://doi.org/10.3389/fped.2014.00148
   PubMed Web of Science ®Google Scholar
• Bernstein, M. S., Morabia, A., & Sloutskis, D. (1999). Definition and prevalence of sedentarism in an urban population. American Journal of Public Health, 89(6), 862–867. https://doi.org/10.2105/ajph.89.6.862
   PubMed Web of Science ®Google Scholar
• Brasil. Ministério da Saúde. DATASUS. Informações de Saúde (TABNET) [Internet]. Ministério da Saúde. Retrieved April 22, 2016, from http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sim/cnv/obt10uf.def
   Google Scholar
• Brazilian associationfor the study of obesity and metabolic syndrome brazilian guidelines on obesity 2016/ABESO – Brazilian association for the study of obesity and metabolic syndrome – 4 Ed. - São Paulo, SP. Retrieved June 14, 2020, from https://abeso.org.br/wp-content/uploads/2019/12/Diretrizes-Download-Diretrizes-Brasileiras-de-Obesidade-2016.pdf
   Google Scholar
• Buono, C., Come, C. E., Witztum, J. L., Maguire, G. F., Connelly, P. W., Carroll, M., & Lichtman, A. H. (2002). Influence of C3 deficiency on atherosclerosis. Circulation, 105(25), 3025–3031. https://doi.org/10.1161/01.cir.0000019584.04929.83
   PubMed Web of Science ®Google Scholar
• Cardiovascular Diseases. Retrieved June 14, 2020, from https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1
   Google Scholar
• Cesar, L. A., Ferreira, J. F., Armaganijan, D., Gowdak, L. H., Mansur, A. P., & Bodanese, L. C. (2014). Diretriz de Doença Coronária Estável. Arquivo Brasileiro de Cardiologia, 103(2), 1–60. http://publicacoes.cardiol.br/2014/diretrizes/2014/Diretriz%20de%20Doen%C3%A7a%20Coron%C3%A1ria%20Est%C3%A1vel.pdf
   PubMedGoogle Scholar
• Chemistry Information Sheet. (2020). Beckman Coulter. Retrieved June 14, 2020, from https://www.beckmancoulter.com/wsrportal/techdocs?docname=/cis/A18469/%25%25/%25_A18469-%25%25_English.pdf
   Google Scholar
• Cieslinski, J. Z., Skare, T. L., Nisihara, R., De Messias-Reason, I. J., & Utiyama, S. R. R. (2018). Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: Association with thrombocytopaenia and seizure. Lupus, 27(3), 372–379. https://doi.org/10.1177/0961203317722846
   PubMed Web of Science ®Google Scholar
• Da Luz, P. L., & Favarato, D. (1999). Doença Coronária Crônica. ArqBrasCardiol, 72(1), 5–21. Retrieved June 25, 2020, from http://publicacoes.cardiol.br/abc/1999/7201/72010002.pdf
   Google Scholar
• Dahl, M., Tybjærg-Hansen, A., Schnohr, P., & Nordestgaard, B. G. (2004). A population-based study of morbidity and mortality in mannose-binding lectin deficiency. Journal of Experimental Medicine, 199(10), 1391–1399. https://doi.org/10.1084/jem.20040111
   PubMed Web of Science ®Google Scholar
• Dommett, R. M., Klein, N., & Turner, M. W. (2006). Mannose-binding lectin in innate immunity: Past, present and future. Tissue Antigens, 68(3), 193–209. https://doi.org/10.1111/j.1399-0039.2006.00649.x
   PubMedGoogle Scholar
• Fumagalli, S., Perego, C., Zangari, R., De Blasio, D., Oggioni, M., De Nigris, F., Snider, F., Garred, P., Ferrante, A. M. R., & De Simoni, M.-G. (2017). Lectin pathway of complement activation is associated with vulnerability of atherosclerotic plaques. Frontiers in Immunology, 8(288). https://doi.org/10.3389/fimmu.2017.00288
   Google Scholar
• Ghiran, I., Barbashov, S. F., Klickstein, L. B., Tas, S. W., Jensenius, J. C., & Nicholson-Weller, A. (2000). Complement receptor 1/CD35 is a receptor for mannan-binding lectin. Journal of Experimental Medicine, 192(12), 1797–1807. https://doi.org/10.1084/jem.192.12.1797
   PubMed Web of Science ®Google Scholar
• Giefing-Kröll, C., Berger, P., Lepperdinger, G., & Grubeck-Loebenstein, B. (2015). How sex and age affect imune responses, susceptility to infections, and response to vaccination. Aging Cell, 14(3), 309–321. https://doi.org/10.1111/acel.12326
   PubMed Web of Science ®Google Scholar
• Haahr-Pedersen, S., Bjerre, M., Flyvbjerg, A., Mogelvang, R., Dominquez, H., Hansen, T. K., Galatius, S., Bech, J., Madsen, J. K., Søgaard, P., & Jensen, J. S. (2009). Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention. The Journal of Invasive Cardiology, 21(1), 13–19.
   PubMed Web of Science ®Google Scholar
• Karbownik-Lewinska, M., Stepniak, J., Marcinkowska, M., Krygier, A., & Lewinski, A. (2020). High normal TSH is associated with lower mannan-binding lectin in women of childbearing age. BMC endocrine disorders, 20(1), 82. https://doi.org/10.1186/s12902-020-00564-x
   PubMed Web of Science ®Google Scholar
• Kilpatrick, D. C., Downing, I., MacDonald, S. L., & Turner, M. L. (2007). MBL really binds to healthy human cells! ScandinavianJournal of Immunology, 66(5), 599–600. https://doi.org/10.1111/j.1365-3083.2007.02003.x
   PubMed Web of Science ®Google Scholar
• Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., … Sirenko, Y. (2019). ESC guidelines on the diagnosis and management of chronic coronary syndromes: The task force for diagnosis and management of chronic coronary syndromes of the European society of cardiology. European Heart Journal, 41(3), 407–477. https://doi.org/10.1093/eurheartj/ehz425
   Web of Science ®Google Scholar
• Landi-Librandi, A. P., & Assis-Pandochi, A. I. (2008). O envolvimento do sistema complemento nos processos de aterogênese. Medicina (Ribeirão Preto), 41(3), 312–326. https://doi.org/10.11606/issn.2176-7262.v41i3p312-326
   Google Scholar
• Lidani, K. C. F., Bavia, L., Ambrosio, A. R., & de Messias-Reason, I. J. (2017). The complement system: A prey of trypanosoma cruzi. Frontiers in Microbiology, 8, 607. https://doi.org/10.3389/fmicb.2017.00607
   PubMed Web of Science ®Google Scholar
• Losin, I. E., Shakhnovich, R. M., Zykov, K. A., & Ruda, M. I. (2010). Level of mannose-binding lectin and phagocytic activity of leukocytes in patients with acute coronary syndrome. Kardiologiia, 54(1), 27–33. https://doi.org/10.18565/cardio.2014.1.27-33
   Google Scholar
• Maiuri, M. C., Grassia, G., Platt, A. M., Carnuccio, R., Ialenti, A., & Maffia, P. (2013). Macrophage autophagy in atherosclerosis. Mediators Inflammation, 2016, 584715. https://doi.org/10.1155/2013/584715
   Google Scholar
• Matthijsen, R. A., Winther, M. P. J., Kuipers, D., van der Made, I., Weber, C., Herias, M. V., Gijbels, M. J. J., & Buurman, W. A. (2009). Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor–deficient mice. Circulation, 119(16), 2188–2195. https://doi.org/10.1161/circulationaha.108.830661
   PubMed Web of Science ®Google Scholar
• Muscari, A. (2000). Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. European Heart Journal, 21(13), 1081–1090. https://doi.org/10.1053/euhj.1999.2013
   PubMed Web of Science ®Google Scholar
• Muscari, A., Bozzoli, C., Puddu, G. M., Sangiorgi, Z., Dormi, A., Rovinetti, C., Descovich, G. C., & Puddu, P. (1995). Association of serum C3 levels with the risk of myocardial infarction. The American Journal of Medicine, 98(4), 357–364. https://doi.org/10.1016/S0002-9343(99)80314-3
   PubMed Web of Science ®Google Scholar
• Nilsson, B., Hamad, O. A., Ahlström, H., Kullberg, J., Johansson, L., Lindhagen, L., Haenni, A., Ekdahl, K. N., & Lind, L. (2014). C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors. European Journal of Clinical Investigation, 44(6), 587–596. https://doi.org/10.1111/eci.12275
   PubMed Web of Science ®Google Scholar
• Nisihara, R. M. (2009). Concentrações séricas da lecticina ligante da manose na Síndrome de Down. Retrieved June 25, 2020, from http://hdl.handle.net/1884/23959
   Google Scholar
• Onat, A., Can, G., Rezvani, R., & Cianflone, K. (2011). Complement C3 and cleavage products in cardiometabolic risk. Clinica Chimica Acta, 412(13–14), 1171–1179. https://doi.org/10.1016/j.cca.2011.03.005
   PubMed Web of Science ®Google Scholar
• Onat, A., Hergenç, G., Can, G., Kaya, Z., & Yüksel, H. (2010). Serum complement C3: A determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. Metabolism: Clinical and Experimental, 59(5), 628–634. https://doi.org/10.1016/j.metabol.2009.09.006
   PubMed Web of Science ®Google Scholar
• Pagowska-Klimek, I., & Cedzynski, M. (2014). Mannan-binding lectin in cardiovascular disease. BioMed Research International, 2014, 1–13. https://doi.org/10.1155/2014/616817
   Web of Science ®Google Scholar
• Palikhe, A., Sinisalo, J., Seppänen, M., Haario, H., Meri, S., Valtonen, V., Nieminen, M. S., & Lokki, M.-L. (2007). SerumComplement C3/C4 ratio, a novel marker for recurrent cardiovascular events. The American Journal of Cardiology, 99(7), 890–895. https://doi.org/10.1016/j.amjcard.2006.11.034
   PubMed Web of Science ®Google Scholar
• Panda, A., Arjona, A., Sapey, E., Bai, F., Fikrig, E., Montgomery, R. R., Lord, J. M., & Shaw, A. C. (2009). Human innate immunosenescence: Causes and consequences for immunity in old age. Trends in Immunology, 30(7), 325–333. https://doi.org/10.1016/j.it.2009.05.004
   PubMed Web of Science ®Google Scholar
• Persson, L., Borén, J., Robertson, A. K. L., Wallenius, V., Hansson, G. K., & Pekna, M. (2004). Lack of complement factor C3, but not factor b, increases hyperlipidemia and atherosclerosis in apolipoprotein E−/− low-density lipoprotein receptor−/− mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(6), 1062–1067. https://doi.org/10.1161/01.ATV.0000127302.24266.40
   PubMed Web of Science ®Google Scholar
• Pesonen, E., Hallman, M., Sarna, S., Andsberg, E., Haataja, R., Meri, S., Persson, K., Puolakkainen, M., Öhlin, H., & Truedsson, L. (2009). Mannose binding lectin as a risk factor for acute coronary syndromes. Annals of Medicine, 41(8), 591–598. https://doi.org/10.1080/07853890903110994
   PubMed Web of Science ®Google Scholar
• Petersen, S., Thiel, S., Jensen, L., Steffensen, R., & Jensenius, J. (2001). An assay for the mannan-binding lectin pathway of complement activation. Journal of Immunological Methods, 257(1–2), 107–116. https://doi.org/10.1016/S0022-1759(01)00453-7
   PubMed Web of Science ®Google Scholar
• Phieler, J., Garcia-Martin, R., Lambris, J. D., & Chavakis, T. (2013). The role of the complement system in metabolic organs and metabolic diseases. Seminars in Immunology, 25(1), 47–53. https://doi.org/10.1016/j.smim.2013.04.003
   PubMed Web of Science ®Google Scholar
• Pilely, K., Rosbjerg, A., Genster, N., Gal, P., Pál, G., Halvorsen, B., Holm, S., Aukrust, P., Bakke, S. S., Sporsheim, B., Nervik, I., Niyonzima, N., Bartels, E. D., Stahl, G. L., Mollnes, T. E., Espevik, T., & Garred, P. (2016). Cholesterol crystals activate the lectin complement pathway via ficolin-2 and mannose-binding lectin: Implications for the progression of atherosclerosis. Journal of Immunology, 196(12), 5064–5074. https://doi.org/10.4049/jimmunol.1502595
   PubMed Web of Science ®Google Scholar
• Ross, R. (1999). Atherosclerosis — An inflammatory disease. New England Journal of Medicine, 340(2), 115–126. https://doi.org/10.1056/NEJM199901143400207
   PubMed Web of Science ®Google Scholar
• Saevarsdottir, S., Oskarsson, O. O., Aspelund, T., Eiriksdottir, G., Vikingsdottir, T., Gudnason, V., & Valdimarsson, H. (2005). Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. Journal of Experimental Medicine, 201(1), 117–125. https://doi.org/10.1084/jem.20041431
   PubMed Web of Science ®Google Scholar
• Schoos, M. M., Munthe-Fog, L., Skjoedt, M., Ripa, R. S., Lønborg, J., Kastrup, J., Kelbæk, H., Clemmensen, P., & Garred, P. (2013). Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction—A magnetic resonance study. Molecular Immunology, 54(3–4), 408–414. https://doi.org/10.1016/j.molimm.2013.01.008
   PubMed Web of Science ®Google Scholar
• Seifert, O. S., Hugo, F., Hansson, G. K., & Bhakdi, S. (1989). Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Laboratory Investigation, 60(6), 747–754.
   PubMed Web of Science ®Google Scholar
• Shaw, A. C., Joshi, S., Greenwood, H., Panda, A., & Lord, J. M. (2010). Aging of the innate immune system. Current Opinion in Immunology, 22(4), 507–513. https://doi.org/10.1016/j.coi.2010.05.003
   PubMed Web of Science ®Google Scholar
• Szeplaki, G., Prohaszka, Z., Duba, J., Rugonfalvi-Kiss, S., Karadi, I., Kokai, M., Kramer, J., Füst, G., Kleiber, M., Romics, L., & Varga, L. (2004). Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis, 177(2), 383–389. https://doi.org/10.1016/j.atherosclerosis.2004.07.022
   PubMed Web of Science ®Google Scholar
• Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018). Fourth universal definition of myocardial infarction (2018). Journal of the American College of Cardiology, 72(18), 2231–2264. https://doi.org/10.1016/j.jacc.2018.08.1038
   PubMed Web of Science ®Google Scholar
• Vengen, I. T., Dale, A. C., Wisetth, R., Midthjell, K., & Videm, V. (2009). Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: Long-term follow-up of the HUNT1 study. Atherosclerosis, 207(1), 239–244. https://doi.org/10.1016/j.atherosclerosis.2009.04.003
   PubMed Web of Science ®Google Scholar
• Vengen, I. T., Madsen, H. O., Garred, P., Platou, C., Vatten, L., & Videm, V. (2012). Mannose-binding lectin deficiency is associated with myocardial infarction: The HUNT2 study in Norway. PLOS ONE, 7(7), e42113. https://doi.org/10.1371/journal.pone.0042113
   PubMed Web of Science ®Google Scholar
• Xavier, H. T., Izar, M. C., Faria Neto, J. R., Assad, M. H., Rocha, V. Z., Sposito, A. C., Fonseca, F. A., Santos, J. E. D., Santos, R. D., Bertolami, M. C., Faludi, A. A., Martinez, T. L. R., Diament, J., Guimarães, A., Forti, N. A., Moriguchi, E., Chagas, A. C. P., Coelho, O. R., & Ramires, J. A. F. (2013). V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arquivos Brasileiros de Cardiologia, 101(Suppl 4), 1–20. https://doi.org/10.5935/abc.2013S010
   Google Scholar
• Yan, W., Che, L., Jiang, J., Yang, F., Duan, Q., Song, H., Liu, X., Shen, Y., & Wang, L. (2016). Depletion of complement system immunity in patients with myocardial infarction. Molecular Medicine Reports, 14(6), 5350–5356. https://doi.org/10.3892/mmr.2016.5912
   PubMed Web of Science ®Google Scholar
• Zhao, Y., Lin, W., Li, Z., Lin, J. T., Wang, S., Zeng, C., Ni, J., & Wang, Y. (2015). High expression of mannose-binding lectin and the risk of vascular complications of diabetes: evidence from a meta-analysis. Diabetes Technology & Therapeutics, 17(7), 490–497. https://doi.org/10.1089/dia.2014.0372
   PubMed Web of Science ®Google Scholar